Kimryn Rathmell

  • Vanderbilt University

    Study revises understanding of cancer metabolism

    Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years. Read More

    Apr. 7, 2021

  • AAAS logo on top of gold MyVU template

    Six Vanderbilt faculty elected as AAAS fellows in 2020

    Six Vanderbilt University faculty members have been elected 2020 fellows of the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers. Read More

    Nov. 24, 2020

  • Vanderbilt University

    Vanderbilt honors 29 distinguished faculty with endowed chairs

    Twenty-nine prominent faculty from across campus comprise Vanderbilt University’s latest endowed chair honorees. They include scholars working in diverse areas—from election analysis and lung cancer research to the nascent field of neurolaw, exploring the brain mechanism underlying legal decision-making. Read More

    Nov. 11, 2020

  • Vanderbilt University

    Grant bolsters kidney cancer immunotherapy research

    W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer. Read More

    May. 10, 2018

  • Six Vanderbilt physicians honored by medical societies

    Six Vanderbilt physicians honored by medical societies

    Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are: Read More

    May. 3, 2018

  • Vanderbilt University

    Ware elected VP of clinical investigation society

    With last week’s election of Lorraine Ware, MD, as vice president of the American Society for Clinical Investigation (ASCI), two faculty members of the Vanderbilt University School of Medicine are among the current officers of the elite physician-scientist honor society. Read More

    Apr. 26, 2018

  • close up of blood vessels

    VICC study sheds new light on Von Hippel-Lindau syndrome

    Investigators at Vanderbilt-Ingram Cancer Center (VICC) and the Virginia Tech Carilion Research Institute (VTCRI) have revealed a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs. Read More

    Mar. 8, 2018

  • Vanderbilt University

    Rathmell elected to ASCO nominating committee

    W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee for the American Society of Clinical Oncology (ASCO). Read More

    Dec. 19, 2017

  • Vanderbilt University

    VU scientists discuss cancer treatments, cellular dynamics

    A trio of Vanderbilt University scientists described their cutting-edge investigations of cellular dynamics and cancer treatment during last week’s Flexner Discovery Lecture. Read More

    Sep. 28, 2017

  • Kidney cancer patient, survivor event set for Sept. 9

    Kidney cancer patient, survivor event set for Sept. 9

    Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898. Read More

    Aug. 17, 2017

  • Vanderbilt University

    Vanderbilt’s W. Kimryn Rathmell named to ASCI leadership post

    W. Kimryn Rathmell, director of the Division of Hematology/Oncology at Vanderbilt University Medical Center, has been named vice president of The American Society for Clinical Investigation. Read More

    Apr. 20, 2017

  • Vanderbilt University

    Celebration honors nine endowed chair recipients

    Nine faculty members who hold endowed chairs were honored and donors were thanked during a festive celebration Sept. 26 at the Student Life Center. Read More

    Sep. 28, 2016

  • Vanderbilt University

    VICC helps launch new alliance for rare kidney cancer

    Children, adolescents or young adults, particularly African-Americans, diagnosed with advanced kidney cancer may actually have a rare form of the disease known as renal medullary carcinoma (RMC) that requires a specialized approach and expert intervention. Read More

    Aug. 18, 2016

  • Vanderbilt University

    Precision medicine already changing cancer treatment strategies

    The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. Read More

    May. 26, 2016

  • Vanderbilt University

    Rathmell to direct Division of Hematology and Oncology

    W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology. Read More

    Aug. 13, 2015